The pharmaceutical sector in Belgium and Europe has reached a historical tipping point, currently navigating a landscape defined by rapid technological shifts, intensifying global competition and complex regulatory changes. As the industry stands at this crossroads, the fundamental questions regarding its long-term viability and strategic direction have never been more urgent. To address these challenges head-on, Itinera is organizing a high-level roundtigh-level roundtable. 

This session is designed to move well beyond standard industry rhetoric, providing instead a candid mapping of the new reality and the difficult choices ahead for policymakers, industry leaders and society at large.

As an independent think tank, Itinera recognizes that the future of healthcare excellence and economic resilience depends entirely on how effectively we navigate this transition. Belgium has long served as a vital pharmaceutical hub, but its continued success is not guaranteed in an evolving global market. The discussion will focus specifically on the strategic positioning of this Belgian hub within the broader European context, asking the necessary questions required to ensure the region remains a preeminent leader in global innovation. By analyzing the trajectory of the industry, the roundtable aims to identify the pivotal decisions and structural reforms necessary to maintain a sustainable, competitive and patient-centric ecosystem.

The complexity of today's pharmaceutical environment requires more than just incremental changes; it demands a clear-eyed look at the structural shifts occurring in R&D, manufacturing and market access. Itinera’s role in this process is to facilitate a space where expertise meets action. By bringing together deep industry knowledge and policy foresight, this initiative seeks to define a trajectory that secures the sector's vital contribution to our economy and our health for decades to come.

This important session will take place on Monday, March 2nd, The Merode in Brussels. The proceedings are scheduled to run from 2 p.m. until 6 p.m., offering an afternoon of high-level debate and strategic insight. Through this initiative, Itinera continues its long-standing commitment to fostering the informed, evidence-based debate needed to shape a prosperous and innovative future for both Belgium and Europe. 

This event is realized with the valued contribution of AstraZeneca and Novartis.